6-aminouracil

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chatterjee, Mitali: 1 article (04/2022)
2.	G Vijayakumar, Balaji: 1 article (04/2022)
3.	Joji, Annu: 1 article (04/2022)
4.	Kannan, Tharanikkarasu: 1 article (04/2022)
5.	Mohanty, Amaresh K: 1 article (04/2022)
6.	Muthuvel, Suresh K: 1 article (04/2022)
7.	Ramesh, Deepthi: 1 article (04/2022)
8.	Sarkar, Deblina: 1 article (04/2022)
9.	Singh, Monica: 1 article (04/2022)
10.	Sriram, Dharmarajan: 1 article (04/2022)

1.	Tuberculosis (Tuberculoses) 04/01/2022 - "Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones were synthesized, for the first time, from indole chalcones and 6-aminouracil, and their ability to inhibit leishmaniasis and tuberculosis (Tb) infections was evaluated. "
2.	Leishmaniasis 04/01/2022 - "Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones were synthesized, for the first time, from indole chalcones and 6-aminouracil, and their ability to inhibit leishmaniasis and tuberculosis (Tb) infections was evaluated. "
3.	Infections 04/01/2022 - "Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones were synthesized, for the first time, from indole chalcones and 6-aminouracil, and their ability to inhibit leishmaniasis and tuberculosis (Tb) infections was evaluated. "